News

Q&A between Cynata CEO Dr Ross Macdonald and the respected and influential industry commentator Professor Paul Knoepfler of the UC Davis School of Medicine Read More...

Read More

Please listen to an interview with Dr Adrian Bloor, UK Chief Investigator in Cynata’s Phase 1 clinical trial in acute steroid resistant graft-versus-host disease (GvHD). [video width="1920" height="1080" mp4="http://cynata.com/wp-content/uploads/2017/05/Cynata-GvHD-Video.mp4"][/video]...

Read More

Please listen to a webcast recording with Cynata Managing Director and CEO Dr Ross Macdonald and FUJFILM Corporate Vice President and General Manager, Regenerative Medicine Business Division, Mr Toshi Ban. [video...

Read More

Nihon Keizai Shimbun March 13, 2017 Fujifilm Group runs clinical trial of medical treatment targeting bone marrow transplant side effects using donated iPS cells in the U.K. Cynata Therapeutics, Ltd., an Australia-based bioventure...

Read More